Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advagraf dosing optimization in kidney transplantation
NCT02161237Phase 4Completed
- Sponsor
- Astellas Pharma
- Start
- Jun 2014
- Primary completion
- Dec 2016
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 4 trial of tacrolimus + Wuzhi capsule in kidney transplant rejection, sponsored by Astellas Pharma. Started Jun 2014; status: completed.
02
Drugs
tacrolimus + Wuzhi capsule
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT02161237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02161237.